Precigen, Inc. (PGEN) Ownership
PGEN ownership summary
as of October 18, 2026- Institutions
- 73.1% of shares outstanding
- Insiders
- 12.64% of shares outstanding
- Shares outstanding
- 356.5M
- Float
- 194.6M shares available to trade
- Short interest
- 24.36% 47.5M shares short
- Days to cover
- 10.24 short interest up 12.5% vs prior month
- Institutions 73.06%
- Insiders 12.64%
- Other investors 14.30%
PGEN top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Patients Capital Management LLC | 5.32% | 19.0M | $121.6M | +1.2M (+6.8%) | June 30, 2026 |
| 2 | BlackRock Inc | 4.79% | 17.1M | $109.6M | +1.9M (+12.6%) | June 30, 2026 |
| 3 | State Street Corp | 3.35% | 12.0M | $76.7M | +1.1M (+10.2%) | June 30, 2026 |
| 4 | Diametric Capital, LP | 2.59% | 9.3M | $59.2M | +2.5M (+36.3%) | June 30, 2026 |
| 5 | Vanguard Capital Management, LLC | 2.21% | 7.9M | $50.5M | +757,164 (+10.6%) | June 30, 2026 |
| 6 | TANG CAPITAL MANAGEMENT LLC | 1.79% | 6.4M | $41.0M | — | June 30, 2026 |
| 7 | Boxer Capital Management, LLC | 1.44% | 5.2M | $32.9M | +1.6M (+47.1%) | June 30, 2026 |
| 8 | Geode Capital Management, LLC | 1.40% | 5.0M | $32.1M | +405,599 (+8.8%) | June 30, 2026 |
| 9 | Iridian Asset Management LLC | 1.13% | 4.0M | $25.8M | +439,233 (+12.2%) | June 30, 2026 |
| 10 | Occam Crest Management L.P. | 1.01% | 3.6M | $23.0M | −663,110 (−15.5%) | June 30, 2026 |
| 11 | Morgan Stanley - Brokerage Accounts | 0.97% | 3.5M | $22.2M | +1.1M (+43.7%) | June 30, 2026 |
| 12 | The Goldman Sachs Group Inc | 0.95% | 3.4M | $21.8M | +55,979 (+1.7%) | June 30, 2026 |
| 13 | FMR Inc | 0.72% | 2.6M | $16.4M | +571,587 (+28.6%) | June 30, 2026 |
| 14 | Vanguard Portfolio Management, LLC | 0.62% | 2.2M | $14.1M | +95,161 (+4.5%) | June 30, 2026 |
| 15 | First Trust Advisors L.P. | 0.56% | 2.0M | $12.9M | +2.0M (0.0%) | June 30, 2026 |
| 16 | Bank of America Corp | 0.52% | 1.8M | $11.8M | +377,135 (+25.6%) | June 30, 2026 |
| 17 | Arrowstreet Capital Limited Partnership | 0.50% | 1.8M | $11.4M | +1.4M (+351.9%) | June 30, 2026 |
| 18 | Northern Trust Corp | 0.50% | 1.8M | $11.4M | +167,590 (+10.4%) | June 30, 2026 |
| 19 | Charles Schwab Investment Management Inc | 0.42% | 1.5M | $9.7M | +55,233 (+3.8%) | June 30, 2026 |
| 20 | Woodline Partners LP | 0.39% | 1.4M | $9.0M | +533 (+0.0%) | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 18 holders added 15.8M shares and 1 cut 663K.
PGEN top mutual fund and ETF holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Patient Opportunity C | 3.35% | 12.0M | $76.7M | −900,000 (−7.0%) | September 30, 2026 |
| 2 | State Street® SPDR® S&P® Biotech ETF | 1.60% | 5.7M | $36.5M | −109,150 (−1.9%) | September 30, 2026 |
| 3 | Vanguard MStar Total Stk Mkt Idx Invest | 1.59% | 5.7M | $36.4M | — | August 31, 2026 |
| 4 | iShares Russell 2000 ETF | 1.40% | 5.0M | $31.9M | −57,600 (−1.1%) | September 30, 2026 |
| 5 | Fidelity Small Cap Index | 0.59% | 2.1M | $13.5M | +17,731 (+0.8%) | July 31, 2026 |
| 6 | iShares Russell 2000 Growth ETF | 0.50% | 1.8M | $11.5M | −2,278 (−0.1%) | September 30, 2026 |
| 7 | First Trust Small Cap Gr AlphaDEX® ETF | 0.47% | 1.7M | $10.8M | +2,982 (+0.2%) | September 30, 2026 |
| 8 | Fidelity Small Cap Growth | 0.47% | 1.7M | $10.7M | — | July 31, 2026 |
| 9 | iShares Biotechnology ETF | 0.36% | 1.3M | $8.2M | −9,688 (−0.8%) | September 30, 2026 |
| 10 | Vanguard Russell 2000 ETF | 0.31% | 1.1M | $7.2M | +12,026 (+1.1%) | September 30, 2026 |
| 11 | Fundstrat Granny Shts US Sm- &Mid-CapETF | 0.31% | 1.1M | $7.1M | — | September 30, 2026 |
| 12 | Schwab US Small-Cap ETF™ | 0.28% | 999K | $6.4M | +675 (+0.1%) | September 30, 2026 |
| 13 | Fidelity Extended Market Index | 0.24% | 872K | $5.6M | −1,606 (−0.2%) | August 31, 2026 |
| 14 | Fidelity Small Cap Growth K6 | 0.24% | 871K | $5.6M | — | July 31, 2026 |
| 15 | First Trust Small Cap Core AlphaDEX® ETF | 0.22% | 789K | $5.0M | — | September 30, 2026 |
| 16 | Calamos Timpani Small Cap Growth I | 0.21% | 769K | $4.9M | +768,795 (0.0%) | August 31, 2026 |
| 17 | JPM Thmtcs Gentc Thrps C2 dist USD | 0.19% | 670K | $4.3M | −5,631 (−0.8%) | September 30, 2026 |
| 18 | iShares Micro-Cap ETF | 0.17% | 609K | $3.9M | −4,200 (−0.7%) | September 30, 2026 |
| 19 | Vanguard Health Care ETF | 0.17% | 601K | $3.8M | +645 (+0.1%) | September 30, 2026 |
| 20 | Stt Strt®SPDR®S&PKenshoNwEcosComposETF | 0.15% | 544K | $3.5M | — | September 30, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
PGEN insider transactions
latest 16| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-30 | Randal J Kirk | Sell | $3.30 | 4,772,781 | $15.8M |
| 2025-12-22 | Randal J Kirk | Sell | $4.18 | 1,900,036 | $7.9M |
| 2025-11-21 | Randal J Kirk | Sell | $3.83 | 937,308 | $3.6M |
| 2025-11-20 | Randal J Kirk | Sell | $4.08 | 942,832 | $3.8M |
| 2025-11-19 | Randal J Kirk | Sell | $4.47 | 1,086,153 | $4.9M |
| 2025-09-30 | Jeffrey B Kindler | Sell | $3.38 | 106,837 | $361,109 |
| 2025-09-30 | Randal J Kirk | Sell | $3.41 | 1,809,667 | $6.2M |
| 2025-09-29 | Jeffrey B Kindler | Sell | $3.60 | 67,523 | $243,083 |
| 2025-09-26 | Harry Jr. Thomasian | Buy | $3.42 | 2,932 | $10,027 |
| 2025-09-26 | Rutul R Shah | Buy | $3.40 | 2,000 | $6,800 |
| 2025-09-25 | Harry Jr. Thomasian | Buy | $3.62 | 8,284 | $29,988 |
| 2025-09-19 | Randal J Kirk | Sell | $3.68 | 3,596,892 | $13.2M |
| 2025-09-18 | Randal J Kirk | Sell | $3.86 | 1,403,360 | $5.4M |
| 2025-09-04 | Nancy H Agee | Buy | $4.60 | 15,000 | $69,000 |
| 2025-08-28 | Nancy H Agee | Buy | $4.65 | 10,645 | $49,499 |
| 2025-08-19 | Nancy H Agee | Buy | $3.20 | 15,360 | $49,152 |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
PGEN shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns PGEN
Institutional investors own 73.1% of Precigen's shares and insiders 12.64%. The largest holder is Patients Capital Management LLC with 5.32% of the shares (19.0M), as of June 30, 2026. Among the top 20 institutions, 18 added shares and 1 reduced their stake in the latest filings. Short interest is 24.36% of the float, or 10.24 days of average trading volume. The share count rose 206.6% since 2014.
Related: PGEN analyst forecast, PGEN key metrics. See the PGEN stock overview for the latest quote and news.
PGEN ownership FAQ
Who owns the most Precigen stock?
The largest shareholders of Precigen are Patients Capital Management LLC (5.32%), BlackRock Inc (4.79%), State Street Corp (3.35%), Diametric Capital, LP (2.59%), Vanguard Capital Management, LLC (2.21%).
What percentage of Precigen is owned by institutions?
Institutions hold 73.1% of Precigen's shares outstanding; insiders hold 12.64%.
Which funds own Precigen?
The largest fund holders of Precigen are Patient Opportunity C (3.35%), State Street® SPDR® S&P® Biotech ETF (1.60%), Vanguard MStar Total Stk Mkt Idx Invest (1.59%), iShares Russell 2000 ETF (1.40%), Fidelity Small Cap Index (0.59%).
What is Precigen's short interest?
47.5M shares of Precigen were sold short, 24.36% of the float; at the average daily volume it would take 10.24 days to cover.
Are insiders buying or selling Precigen?
Of the latest 16 reported insider transactions in Precigen (since August 19, 2025), 6 were purchases and 10 were sales.
How many shares of Precigen are outstanding?
Precigen has 356.5M shares outstanding, of which 194.6M are in the public float.